Opening Plenary Panel: Thriving or Surviving – An Analysis of the Advanced Therapies Landscape Within Europe & What the Future Holds

06 Sep 2023
09:00
Auditorium
SPONSORED BY
Dark Horse Consulting Group
FUJIFILM Diosynth Biotechnologies

Panel Participants: 

Chairperson: Anthony Davies, Founder & Chief Executive Officer, Dark Horse Consulting Group 

  • Ben Doak, Head of Innovative Treatments, NHS England  
  • Elisabetta Zanon, Director of EU Public Affairs & Advocacy, Alliance for Regenerative Medicine  
  • Helen Tayton-Martin, Chief Business & Strategy Officer, Adaptimmune  
  • Almira Bartolome, Executive Director, Commercial Development, Advanced Therapies & Vaccines, FUJIFILM Diosynth Biotechnologies 
  • Miguel Forte, Chief Executive Officer, Kiji Therapeutics, President-Elect, ISCT

 

Speakers

Almira Bartolome
Executive Director, Commercial Development, Advanced Therapies & Vaccines
FUJIFILM Diosynth Biotechnologies
Anthony Davies
Founder & Chief Executive Officer
Dark Horse Consulting Group
Ben Doak
Head of Innovative Treatments
NHS England
Elisabetta Zanon
Director of EU Public Affairs & Advocacy
Alliance for Regenerative Medicine
Helen Tayton-Martin
Chief Business & Strategy Officer
Adaptimmune
Miguel Forte
Chief Executive Officer, Kiji Therapeutics, President-Elect
ISCT